Consumer: Page 4

How will the Quidel, Ortho deal impact the point-of-care market?
By Bruce Carlson
The company that can impact the point-of-care market drives the future. The COVID-19 pandemic made that point visible, but the point-of-care sector was always significant, even before the pandemic. Point-of-care markets (and the companies that served them) grew faster than other markets.
January 3, 2022
2021 12 30 00 31 3981 Business Graph Money Stocks 400
Co-Diagnostics to buy Idaho Molecular, Advanced Conceptions
By LabPulse.com staff writers
Co-Diagnostics said it expects the acquisition will streamline the commercialization of the Eikon platform and YourTest polymerase chain reaction (PCR) device as it nears completion and prepares for a market release with an easy-to-use, sample-to-result COVID-19 test.
December 22, 2021
2020 04 14 22 00 7772 Business Men Handshake 400
FDA tightens policy on reviews of lab-developed tests
By Brian Casey
In a November 15 press release, the FDA said it was withdrawing its policy that directed the agency to not enforce premarket review requirements for LDTs. The agency said it was taking the action to "help ensure that COVID-19 tests are accurate and reliable."
November 14, 2021
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400
Personalis updates Next biomarker platform
By LabPulse.com staff writers
The Next platform now includes the following updated features:
November 4, 2021
2021 11 05 18 35 5749 Carcinoid Neuroendocrine Tumor 400
Diabetes testing market poised for growth
By Bruce Carlson
However, technological advances and increased knowledge of diabetes have led to two new areas driving the diabetes testing market: continuous glucose monitoring (CGM) and hemoglobin A1c (HbA1c) testing.
November 1, 2021
2021 09 27 23 55 5067 Diabetes Insulin Glucose Blood 400
FDA authorizes 11th over-the-counter COVID-19 test
By LabPulse.com staff writers
The FDA issued an emergency use authorization for the Detect COVID-19 Test, an OTC COVID-19 diagnostic molecular test. The test requires the use of a compatible smartphone and a downloadable app to provide testing instructions and delivers results in about one hour, the FDA said.
October 28, 2021
2019 02 13 19 24 5396 Fda Logo V2 400
COVID-19 tests attempt to prove at-home testing concept can work
By Daniel Granderson
These COVID-19 tests were granted separate emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) earlier in 2021 and all require nasal swab specimens from patients.
August 22, 2021
2021 08 18 22 53 0531 Covid 19 Self Swab Test 400
Latin America's IVD market to reach $4.2 billion in 2025
By Bruce Carlson
The forecast growth rate for Latin America will therefore slightly outpace what's expected for the the U.S., which is the largest IVD market at $41.3 billion and makes up approximately 40%-45% of the global IVD market.
August 16, 2021
2019 02 14 22 33 2984 Latin America 400
Unilabs to deploy Ibex's AI platform in Europe
By LabPulse.com staff writers
After the platform is rolled out in Sweden, Ibex's Galen platform will be deployed in 16 countries. The platform is trained to detect cancer and other clinical findings by analyzing images from tissue biopsies. Its AI-generated insights include case prioritization worklists, cancer heatmaps, tumor grading and measurement, streamlined reporting tools, and more.
July 20, 2021
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
GE Healthcare collaborates with Sophia Genetics
By LabPulse.com staff writers
The companies aim to develop new artificial intelligence-powered analytics and workflow solutions to serve both the clinical and biopharma markets. They will combine data from the GE Healthcare Edison platform and the Sophia DDM cloud-based platform. The Edison platform integrates and assimilates data and applies analytics and algorithms to generate clinical, operational, and financial insights. The DDM software-as-a-service provides analytical genomic insights.
July 5, 2021
2021 01 12 17 49 6308 Medicine Clinical Options 400
Tecan to acquire Paramit for $1B
By LabPulse.com staff writers
The acquisition will significantly accelerate Tecan's entry into the medical device market and build Paramit's capabilities and market leadership in life sciences and IVDs, the companies said in a statement. The deal will expand Paramit's reach in the European and Asian markets, including China.
June 23, 2021
2020 04 14 22 00 7772 Business Men Handshake 400
POC test market reaches $29.3B as COVID-19 revenues boom
By Bruce Carlson
In addition, new technologies and increased demand contributed to growth in the markets. A contributing factor to slower growth in some segments was pricing strategies that continued to discount the cost of POC diagnostic testing in some segments and higher cost in other segments of testing.
April 19, 2021
2021 04 19 16 59 1236 Fingerprick Blood 400
Previous Page
Page 4 of 8
Next Page